CURRENT AFFAIRS

Detailed explanation-1: -The stock has appreciated 60% in the past three months in anticipation of a transaction. Mumbai: US private equity giant KKR has agreed to acquire about 54 per cent stake in Mumbai-based drug manufacturer JB Chemicals & Pharmaceuticals, one of the oldest pharma companies in India, for Rs 3, 100 crore.

Detailed explanation-2: -About 18 months after taking over JB Chemicals & Pharmaceuticals Ltd. (JB) from the promoters for ₹3, 100 crore, private equity major KKR, through a new leadership team, has brought in a marked improvement in its performance, functioning and ranking in the pharma industry, a top executive said.

Detailed explanation-3: -JB Chemicals supplies products in the cardiac, gastrointestinal and anti-infective therapeutic areas across the branded formulations market. Besides India, it counts Russia and South Africa as its home markets.

Detailed explanation-4: -2424 Crores and EBITDA at a strong Rs 550 Crores, JB Pharma is the fastest growing pharmaceutical company in FY 2021-22 and Q1 of FY 2022-23, ranked at No. 23.

Detailed explanation-5: -After this transaction, an open offer will be launched to acquire 20.93 million fully paid-up equity shares of JB Chemicals, representing 26 per cent. The open offer, too, is being made at a price of Rs 745 per share, said the company statement. The deal size is estimated to be around $500 million (Rs 3, 750 crore).